Fresenius Medical Care AG & Co. KGaA (ETR: FME) was the recipient of a ratings changes during the seven days:
- Fresenius Medical Care AG & Co. KGaA had its “hold” rating reaffirmed by analysts at Deutsche Bank. They now have a $64.00 (€49) price target on the stock.
- Fresenius Medical Care AG & Co. KGaA had its “hold” rating reaffirmed by analysts at Commerzbank Corporates & Markets. They now have a $74.67 (€57) price target on the stock.
- Fresenius Medical Care AG & Co. KGaA had its “buy” rating reaffirmed by analysts at Societe Generale. They now have a $89.61 (€69) price target on the stock.
- Fresenius Medical Care AG & Co. KGaA had its price target lowered by analysts at Piper Jaffray from $37.00 (€28) to $34.00 (€26).
- Fresenius Medical Care AG & Co. KGaA had its “neutral” rating reaffirmed by analysts at Goldman Sachs. They now have a $68.83 (€53) price target on the stock.
Shares of Fresenius Medical Care AG & Co. KGaA opened at 52.762 on Friday. Fresenius Medical Care AG & Co. KGaA has a one year low of €47.982 and a one year high of €60.24. The stock’s 50-day moving average is currently €56.72.
Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
